Duloxetine 60 MG

DRUG8 trials

Conditions

Acute Post-operative PainBDNFBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBurning Mouth SyndromeChronic Post Operative PainDrug-Related Side Effects and Adverse Reactions

Phase 1

The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery.

Not yet recruitingNCT05949229

Amira Hassan Ahmed AliPost Operative Delirium

Start: 2023-08-31End: 2026-12-31Target: 42Updated: 2023-07-17

Phase 2

Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough

RecruitingNCT05110144

Mayo ClinicRefractory Chronic Cough

Start: 2021-11-01End: 2026-12-01Target: 50Updated: 2026-01-21

Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough

RecruitingNCT05120934

Mayo ClinicInterstitial Lung Disease

Start: 2021-11-01End: 2026-10-01Target: 25Updated: 2026-01-21

Duloxetine Impact on Postoperative Pain Control and Outcomes

TerminatedNCT05611749

Scripps HealthAcute Post-operative Pain, Chronic Post Operative Pain, Narcotic Use +2

Start: 2023-05-30End: 2024-03-25Updated: 2025-05-04

Phase 3

A Study of Duloxetine in Fibromyalgia

CompletedNCT01552057

Eli Lilly and CompanyFibromyalgia

Start: 2012-03-31End: 2013-12-31Updated: 2015-01-16

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

NCT06025474

Federico II UniversityBurning Mouth Syndrome

Start: 2023-01-01End: 2024-07-24Target: 203Updated: 2023-09-06

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Not yet recruitingNCT06407401

European Organisation for Research and Treatment of Cancer - EORTCBreast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III +4

Start: 2024-12-31End: 2028-11-30Target: 399Updated: 2024-11-05

Unknown Phase

Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)

RecruitingNCT07203339

Hospital de Clinicas de Porto AlegreBDNF, Duloxetine, EEG +2

Start: 2025-09-30End: 2028-12-31Target: 610Updated: 2026-01-06

Related Papers

Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial

Current Neuropharmacology2025-02-283 citations

A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients

Arthritis Research & Therapy2015-08-2148 citations